Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Large-scale testing (Phase 3)Study completedNCT00149929
What this trial is testing

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

Who this might be right for
Renal Transplant
Novartis 246
Large-scale testing (Phase 3)Ended earlyNCT00137345
What this trial is testing

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 500
Testing effectiveness (Phase 2)Study completedNCT00307125
What this trial is testing

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Who this might be right for
Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 757
Post-approval studies (Phase 4)Study completedNCT04033276
What this trial is testing

IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies

Who this might be right for
Renal Transplant
Seoul National University Hospital 50
Post-approval studies (Phase 4)Study completedNCT00238953
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 30
Post-approval studies (Phase 4)Study completedNCT00154310
What this trial is testing

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis 300
Post-approval studies (Phase 4)Study completedNCT00306397
What this trial is testing

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
University Hospital, Basel, Switzerland 100
Large-scale testing (Phase 3)Study completedNCT00154284
What this trial is testing

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Who this might be right for
Organ Transplantation, Renal Transplantation
Novartis 114
Post-approval studies (Phase 4)Study completedNCT02723591
What this trial is testing

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Global Development, Inc. 599
Large-scale testing (Phase 3)Study completedNCT06001320
What this trial is testing

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsCMV
Virginia Commonwealth University 30
Post-approval studies (Phase 4)Ended earlyNCT01371344
What this trial is testing

A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 47
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Post-approval studies (Phase 4)Ended earlyNCT00956293
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 207
Post-approval studies (Phase 4)Study completedNCT03713645
What this trial is testing

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Temple University 36
Not applicableUnknownNCT01982903
What this trial is testing

Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants

Who this might be right for
Kidney Failure
Universitaire Ziekenhuizen KU Leuven 180
Large-scale testing (Phase 3)Study completedNCT01023815
What this trial is testing

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Who this might be right for
de Novo Kidney Transplant RecipientsRenal Transplantation
Novartis 330
Post-approval studies (Phase 4)Study completedNCT01649427
What this trial is testing

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Who this might be right for
Pharmacokinetics Study in de Novo Kidney Transplantation
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT00413920
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 222
Next Page